Indexed keywords
ANTITHROMBIN;
ARGATROBAN;
BLOOD CLOTTING FACTOR 10A;
BLOOD CLOTTING FACTOR 10A INHIBITOR;
CARBOHYDRATE DERIVATIVE;
CHONDROITIN SULFATE;
DANAPAROID;
DERMATAN;
FONDAPARINUX;
HEPARAN;
HEPARIN;
HEPARIN LYASE;
HIRULOG;
LEPIRUDIN;
LOW MOLECULAR WEIGHT HEPARIN;
PENTASACCHARIDE;
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
SANORG 123781A;
SULODEXIDE;
THROMBOCYTE FACTOR 4;
VESSEL DUE F;
ANAPHYLAXIS;
BLEEDING;
BLOOD CLOTTING TIME;
CONTINUOUS INFUSION;
DISEASE SEVERITY;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
DRUG MEGADOSE;
HEART ARREST;
HEMODIALYSIS;
HEMODIALYSIS PATIENT;
HEPARIN INDUCED THROMBOCYTOPENIA;
HUMAN;
LETTER;
PARTIAL THROMBOPLASTIN TIME;
PRIORITY JOURNAL;
SINGLE DRUG DOSE;
SURVIVAL;
THROMBOCYTE ACTIVATION;
THROMBOCYTE AGGREGATION;
THROMBOCYTE COUNT;
VASCULAR ENDOTHELIUM;
ANTICOAGULANTS;
HEPARIN;
HUMANS;
KIDNEY FAILURE, CHRONIC;
RENAL DIALYSIS;
THROMBOCYTOPENIA;
1
19644398319
When heparins promote thrombosis. Review of heparin-induced thrombocytopenia
Jang I, Hursting MJ. When heparins promote thrombosis. Review of heparin-induced thrombocytopenia. Circulation 2005 ; 111: 2671-2671.
(2005)
Circulation , vol.111
, pp. 2671-2671
Jang, I.1
Hursting, M.J.2
2
4644242157
Heparin-induced thrombocytopenia: Recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: Recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 ; 126 (Suppl 3). 311S - 311S.
(2004)
Chest , vol.126
, Issue.SUPPL. 3
Warkentin, T.E.1
Greinacher, A.2
3
13544253722
The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy
Hassell K. The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy. Chest 2005 ; 127 (Suppl 2). 1S - 1S.
(2005)
Chest , vol.127
, Issue.SUPPL. 2
Hassell, K.1
4
22644439706
Heparin-induced thrombocytopenia during renal replacement therapy
Davenport A. Heparin-induced thrombocytopenia during renal replacement therapy. Hemodial Int 2004 ; 8: 295-295.
(2004)
Hemodial Int , vol.8
, pp. 295-295
Davenport, A.1
5
15544381992
Unfractionated heparin, low molecular weight heparins, and pentasaccharide: Basic mechanism of action, pharmacology, and clinical use
Bick RL, Walenga J, Fareed J, Hoppenstaedt DA. Unfractionated heparin, low molecular weight heparins, and pentasaccharide: Basic mechanism of action, pharmacology, and clinical use. Hematol Oncol Clin North Am 2005 ; 19: 1-1.
(2005)
Hematol Oncol Clin North Am , vol.19
, pp. 1-1
Bick, R.L.1
Walenga, J.2
Fareed, J.3
Hoppenstaedt, D.A.4
6
14844321969
From heparins to factor Xa inhibitors and beyond
Alban S. From heparins to factor Xa inhibitors and beyond. Eur J Clin Invest 2005 ; 35 (Suppl 1). 12-12.
(2005)
Eur J Clin Invest , vol.35
, Issue.SUPPL. 1
, pp. 12-12
Alban, S.1
7
1542645757
Fondaparinux (Arixtra) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins
Parody R, Oliver A, Souto JC, Fontcouberta J. Fondaparinux (Arixtra) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins. Haematologica 2003 ; 88: 32-32.
(2003)
Haematologica , vol.88
, pp. 32-32
Parody, R.1
Oliver, A.2
Souto, J.C.3
Fontcouberta, J.4
8
14044251422
Use of fondaparinux (ARIXTRA) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II
Haase M, Bellomo R, Rocktaeschel J. Use of fondaparinux (ARIXTRA) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II. Nephrol Dial Transplant 2005 ; 20: 444-444.
(2005)
Nephrol Dial Transplant , vol.20
, pp. 444-444
Haase, M.1
Bellomo, R.2
Rocktaeschel, J.3
9
0031974383
Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide
Harenberg J. Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide. Med Res Rev 1998 ; 18: 1-1.
(1998)
Med Res Rev , vol.18
, pp. 1-1
Harenberg, J.1
